Rosalie A Scholtes (Rosalie Scholtes)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Skeletal Muscle

Cardiovascular Risk Factors

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Rosalie A Scholtes, Charlotte M Mosterd, Anne C Hesp, Mark M Smits, Hiddo J Lambers Heerspink, Daniël H van Raalte
Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial. Diabetes, obesity & metabolism (2022)
Taha Sen, Rosalie A Scholtes, Peter J Greasley, David Z I Cherney, Claire C J Dekkers, Marc G Vervloet, Alexander H J Danser, Sean J Barbour, Cecilia Karlsson, Ann Hammarstedt, Qiang Li, Gozewijn D Laverman, Petter Bjornstad, Daniel H van Raalte, Hiddo J Lambers Heerspink
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND. Diabetes, obesity & metabolism 24 (8) (2022)
Rosalie A Scholtes, Michaël J B van Baar, Yuliya Lytvyn, Petter Bjornstad, Max Nieuwdorp, David Z I Cherney, Daniel H van Raalte
Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both? Diabetes, obesity & metabolism (2020)
Rosalie A Scholtes, Daniel H van Raalte, Ricardo Correa-Rotter, Robert D Toto, Hiddo J Lambers Heerspink, Valerie Cain, C David Sjöström, Peter Sartipy, Bergur V Stefánsson
The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis. Diabetes, obesity & metabolism 22 (4) (2019)